BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma YS, Liu JB, Lin L, Zhang H, Wu JJ, Shi Y, Jia CY, Zhang DD, Yu F, Wang HM, Yin YZ, Jiang XH, Wang PY, Tian LL, Cao PS, Wu XM, Lu HM, Gu LP, Zhang JJ, Cong GJ, Luo P, Zhong XM, Cai B, Shi MX, Zhang SQ, Li L, Zhang WJ, Liu Y, Li ZZ, Wu TM, Wu ZJ, Wang GR, Lv ZW, Ling CC, Chu KJ, Fu D. Exosomal microRNA-15a from mesenchymal stem cells impedes hepatocellular carcinoma progression via downregulation of SALL4. Cell Death Discov 2021;7:224. [PMID: 34455417 DOI: 10.1038/s41420-021-00611-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ma YS, Hou LK, Yao SH, Liu JB, Yu XC, Shi Y, Yang XL, Wu W, Wu CY, Jiang GX, Fu D. Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer. Mol Ther Oncolytics 2021;22:326-35. [PMID: 34553022 DOI: 10.1016/j.omto.2021.07.005] [Reference Citation Analysis]
2 Álvarez C, Quiroz A, Benítez-Riquelme D, Riffo E, Castro AF, Pincheira R. SALL Proteins; Common and Antagonistic Roles in Cancer. Cancers (Basel) 2021;13:6292. [PMID: 34944911 DOI: 10.3390/cancers13246292] [Reference Citation Analysis]
3 Sun B, Xu L, Bi W, Ou W. SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance. IJMS 2022;23:2053. [DOI: 10.3390/ijms23042053] [Reference Citation Analysis]
4 Tang J, He J, Feng C, Tu C. Exosomal MiRNAs in Osteosarcoma: Biogenesis and Biological Functions. Front Pharmacol 2022;13:902049. [PMID: 35592419 DOI: 10.3389/fphar.2022.902049] [Reference Citation Analysis]
5 Lin J, Lin W, Bai Y, Liao Y, Lin Q, Chen L, Wu Y. Identification of exosomal hsa-miR-483-5p as a potential biomarker for hepatocellular carcinoma via microRNA expression profiling of tumor-derived exosomes. Exp Cell Res 2022;:113232. [PMID: 35659970 DOI: 10.1016/j.yexcr.2022.113232] [Reference Citation Analysis]
6 Khashkhashi Moghadam S, Bakhshinejad B, Khalafizadeh A, Mahmud Hussen B, Babashah S. Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma. J Cell Mol Med 2021. [PMID: 34907642 DOI: 10.1111/jcmm.17126] [Reference Citation Analysis]
7 Shang C, Ke M, Liu L, Wang C, Liu Y, Zheng X. Exosomes From Cancer-Associated Mesenchymal Stem Cells Transmit TMBIM6 to Promote the Malignant Behavior of Hepatocellular Carcinoma via Activating PI3K/AKT Pathway. Front Oncol 2022;12:868726. [PMID: 35720012 DOI: 10.3389/fonc.2022.868726] [Reference Citation Analysis]
8 Shi Y, Liu JB, Deng J, Zou DZ, Wu JJ, Cao YH, Yin J, Ma YS, Da F, Li W. The role of ceRNA-mediated diagnosis and therapy in hepatocellular carcinoma. Hereditas 2021;158:44. [PMID: 34758879 DOI: 10.1186/s41065-021-00208-7] [Reference Citation Analysis]
9 Shao B, Qin YF, Ren SH, Peng QF, Qin H, Wang ZB, Wang HD, Li GM, Zhu YL, Sun CL, Zhang JY, Li X, Wang H. Structural and Temporal Dynamics of Mesenchymal Stem Cells in Liver Diseases From 2001 to 2021: A Bibliometric Analysis. Front Immunol 2022;13:859972. [PMID: 35663940 DOI: 10.3389/fimmu.2022.859972] [Reference Citation Analysis]
10 Sanmartin MC, Borzone FR, Giorello MB, Yannarelli G, Chasseing NA. Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Biological Carriers for Drug Delivery in Cancer Therapy. Front Bioeng Biotechnol 2022;10:882545. [DOI: 10.3389/fbioe.2022.882545] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]